The role of red cell genotyping for transfusion management in thalassemia
Keywords:
-Abstract
-
Downloads
References
Paiboonsukwong K, Jopang Y, Winichagoon P, Fucharoen S. Thal-assemia in Thailand. Hemoglobin. 2022;46:53-7.
Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A. 2021 Thalassaemia International Federation guidelines for the management of transfusion-dependent thalassemia. Hemasphere. 2022;6:e732.
Watanaboonyongcharoen P, Pruksa C, Onpuns S, Rojnuckarin P. Usefulness of red cell genotyping for Thai transfusion-dependent thalassemia patients. The 25th Regional Congress of the ISBT. London: The International Society of Blood Transfusion; 2015.
Watanaboonyongcharoen P, Akkawat B, Tohthong T, Roinuckarin P. High B-cell activating factor levels in multi-transfused thalassemia patients. Transfus Med. 2021;31:350-6.
Shah F, Wood E, Maggio A. Blood transfusion. In: Taher AT, Farmakis D, porter JB, Cappellini MD, Musallam KM, editors. Guidelines for the management of transfusion-dependent B-thalassaemia (TDT). 5 ed. Thalassaemia International Federation; 2025. p. 44-69.
Trompeter S, Baxter L, McBrearty M, Zatkya E, Porter J. Sample acceptance time criteria, electronic issue and alloimmunisation in thalassaemia. Transfus Med. 2015;25:414-7.
Watanaboonyongcharoen P. The guideline for blood transfusion in thalassemia patients. In: Torcharas K, Charoenkwan P, editors.
Clinical practice guideline for the management of anemia and thalassemia. Bangkok: Thai Society of Hematology; 2020 p. 115-22.
Watanaboonyongcharoen P, Onspun S, Rojnuckarin P. Clinical impacts of DNA-based typing and provision of antigen-matched
red blood cell units for chronically transfused patients with thalassemia. Immunohematology. 2020;36:137-45.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Hematology and Transfusion Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
